SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-190442
Filing Date
2020-07-09
Accepted
2020-07-09 16:08:59
Documents
5
Period of Report
2020-08-19
Effectiveness Date
2020-07-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d932985ddef14a.htm DEF 14A 321588
2 GRAPHIC g932985g34d37.jpg GRAPHIC 41578
3 GRAPHIC g932985n11.jpg GRAPHIC 31716
4 GRAPHIC g932985n12.jpg GRAPHIC 60897
5 GRAPHIC g932985new2.jpg GRAPHIC 83652
  Complete submission text file 0001193125-20-190442.txt   619237
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 201020588
SIC: 2836 Biological Products, (No Diagnostic Substances)